Literature DB >> 7552013

Intraoperative radiotherapy for pancreatic carcinoma.

R Kasperk1, P Klever, D Andreopoulos, V Schumpelick.   

Abstract

Intraoperative radiotherapy (IORT) with an electron beam is a therapeutic modality employed predominantly in tumours with a high risk of local recurrence. In this department 35 patients with proven adenocarcinoma of the pancreas underwent surgery and IORT, while 41 patients underwent surgery only. Irradiated patients suffered more serious postoperative complications (21 per cent versus 7 per cent), spent more time in hospital (32 days versus 26 days) and did not show a survival advantage (median of 326 days versus 366 days for two patients with curative resection). Anastomotic breakdown (twp patients), abscess formation (two patients) and pancreatitis in the pancreatic remnant (one patient) occurred only in this group. It is concluded that IORT may increase the risk of postoperative complications. As, on the basis of experimental data, an additional serious long-term risk is to be expected, application of IORT should be limited to well controlled study conditions.

Entities:  

Mesh:

Year:  1995        PMID: 7552013     DOI: 10.1002/bjs.1800820934

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Different radiogenic effects on microcirculation in healthy pancreas and in pancreatic carcinoma of the rat.

Authors:  Eduard Ryschich; Jan Schmidt; Thorsten Loeffler; Michel Eble; Martha Maria Gebhard; Wolfgang Harms; Ernst Klar
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

2.  Recurrence after resection for ductal adenocarcinoma of the pancreas.

Authors:  C Sperti; C Pasquali; A Piccoli; S Pedrazzoli
Journal:  World J Surg       Date:  1997-02       Impact factor: 3.352

3.  The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis.

Authors:  Liang Jin; Ning Shi; Shiye Ruan; Baohua Hou; Yiping Zou; Xiongfeng Zou; Haosheng Jin; Zhixiang Jian
Journal:  Radiat Oncol       Date:  2020-04-09       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.